IP Library Granted Patent US 7,618,432
Granted Patent B2
US 7,618,432 · App. 10/856,494 · Granted Nov 17, 2009

Valvuloplasty devices and methods

Assignee: InterValve, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,618,432
App. No.
10/856,494
Granted
Nov 17, 2009
Kind
B2
Abstract

The present invention provides an aortic valvuloplasty catheter which, in one preferred embodiment, has a tapered distal balloon segment that anchors within the left ventricle outflow track of the patient's heart and a rounded proximal segment which conforms to the aortic sinuses forcing the valve leaflets open. In addition, this embodiment of the valvuloplasty catheter includes a fiber-based balloon membrane, a distal pigtail end hole catheter tip, and a catheter sheath.

Claims (27)

1. A method of performing aortic valvuloplasty comprising:

providing a catheter having a balloon;

advancing said catheter towards an aortic valve;

expanding a first region of said balloon to a first maximum inflated diameter so as to contact a patient's ventricular outflow tract to reduce downstream migration of said balloon;

expanding a second region of said balloon to a second maximum inflated diameter so as to hyperextend a patient's valve leaflets against an aortic sinus; and,

expanding a third region of said balloon to a third maximum inflated diameter that is smaller than said first and second maximum inflation diameter and substantially equal to a diameter of a patient's valve annulus so as to prevent dissection of said annulus;

wherein said third region is located between said first region and said second region.

2. The method as set forth in claim 1 , wherein said first region expands at a first media pressure and said second region expands at a second media pressure.

3. The method as set forth in claim 1 , wherein said first region has a first compliancy, said second region has a second compliancy and said third region has a third compliancy.

4. The method as set forth in claim 3 , wherein said first region expands prior to expansion by said second region.

5. The method as set forth in claim 1 , further comprising, allowing perfusion of blood past said expandable member.

6. The method as set forth in claim 1 , further comprising measuring a pressure proximal and distal to said aortic valve.

7. The method as set forth in claim 1 , further comprising depositing an anti-restenosis agent in a region of said aortic valve.

8. The method according to claim 1 , further comprising:

providing a sheath movable over said catheter such that movement of said sheath controls exposure of said balloon; and,

stabilizing said balloon with said sheath after expanding said balloon.

9. The method of claim 1 , wherein said first and second media pressures are substantially equal.

10. A method of treating a heart valve comprising:

identifying a target heart valve having diseased leaflets;

delivering a balloon an at said diseased leaflets; and,

expanding a first region of said balloon to a first maximum inflated diameter so as to engage a patient's ventricular outflow tract to reduce downstream migration of said balloon;

expanding a second region of said balloon to a second maximum inflated diameter so as to hyperextend a patient's valve leaflets against an aortic sinus; and,

expanding a third region of said balloon to a third maximum inflated diameter that is smaller than said first maximum inflated diameter and second maximum inflated diameter and not greater than a diameter of a patient's valve annulus so as to prevent distension of said annulus

wherein said third region is located between said first region and said second region.

11. A method according to claim 10 , wherein said first region expands at a first media pressure and said second region expands at a second media pressure.

12. A method according to claim 11 , wherein said first region has a first compliancy, said second region has a second compliancy and said third region has a third compliancy.

13. A method according to claim 11 , wherein said first region is shared to conform to a share of said ventricular outflow tract when expanded to said first maximum inflated diameter.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2025
From: INTERVALVE MEDICAL, INC.
To: VENUS MEDTECH OF AMERICA CORP.
Reel/Frame 071767/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2018
From: INTERVALVE, INC.
To: INTERVALVE MEDICAL, INC.
Reel/Frame 046855/0290 →
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2017
From: OXFORD FINANCE LLC
To: INTERVALVE, INC.
Reel/Frame 043946/0420 →
SECURITY INTEREST Recorded Jan 15, 2016
From: INTERVALVE, INC.
To: OXFORD FINANCE LLC
Reel/Frame 037500/0429 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2009
From: PEDERSEN, WESLEY; VAN TASSEL, ROBERT A.; SCHWARTZ, ROBERT S.; BRUCKER, GREGORY G.; GREENHALGH, SKOTT E.
To: INTERVALVE, INC.
Reel/Frame 023328/0504 →
Continuity (3)
Provisional Application 6054789600 · Feb 25, 2004
Provisional Application 6048863500 · Jul 18, 2003
Related Publication 20050090846A1 · Apr 28, 2005